93 related articles for article (PubMed ID: 35035441)
1. Pre-morbidity and COVID-19 disease outcomes in Pakistani population: A cross-sectional study.
Toori KU; Qureshi MA; Chaudhry A
Pak J Med Sci; 2022; 38(1):287-292. PubMed ID: 35035441
[TBL] [Abstract][Full Text] [Related]
2. Time to negative PCR in various disease categories of COVID-19 infection in Pakistani population.
Toori KU; Chaudhry A; Qureshi MA
Pak J Med Sci; 2022; 38(1):243-247. PubMed ID: 35035433
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil to lymphocyte ratio (NLR) in COVID-19: A cheap prognostic marker in a resource constraint setting.
Toori KU; Qureshi MA; Chaudhry A; Safdar MF
Pak J Med Sci; 2021; 37(5):1435-1439. PubMed ID: 34475926
[TBL] [Abstract][Full Text] [Related]
4. Lymphopenia: A useful predictor of COVID-19 disease severity and mortality.
Toori KU; Qureshi MA; Chaudhry A
Pak J Med Sci; 2021; 37(7):1984-1988. PubMed ID: 34912430
[TBL] [Abstract][Full Text] [Related]
5. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
6. Analyzing the Outcomes of COVID-19 Infection on Patients With Comorbidities: Insights From Hospital-Based Study.
Bakthavatchalam R; Bakthavatchalam S; Ravikoti S; Shanmukham B; Reddy KS; Pallavali JR; Gaur A; Geetha J; Varatharajan S
Cureus; 2024 Mar; 16(3):e55358. PubMed ID: 38562329
[TBL] [Abstract][Full Text] [Related]
7. Obesity, diabetes, hypertension and severe outcomes among inpatients with coronavirus disease 2019: a nationwide study.
Bailly L; Fabre R; Courjon J; Carles M; Dellamonica J; Pradier C
Clin Microbiol Infect; 2022 Jan; 28(1):114-123. PubMed ID: 34537362
[TBL] [Abstract][Full Text] [Related]
8. Diabetes Mellitus and Hypertension Increase Risk of Death in Novel Corona Virus Patients Irrespective of Age: a Prospective Observational Study of Co-morbidities and COVID-19 from India.
Gupta A; Nayan N; Nair R; Kumar K; Joshi A; Sharma S; Singh J; Kapoor R
SN Compr Clin Med; 2021; 3(4):937-944. PubMed ID: 33718779
[TBL] [Abstract][Full Text] [Related]
9. Prolonged Oxygen Therapy Post COVID-19 Infection: Factors Leading to the Risk of Poor Outcome.
Ray A; Chaudhry R; Rai S; Mitra S; Pradhan S; Sunder A; Nag DS
Cureus; 2021 Feb; 13(2):e13357. PubMed ID: 33633916
[TBL] [Abstract][Full Text] [Related]
10. Wallop of Symptoms and Co-morbidities on COVID-19 Outcome.
Abo ElNaga HH; AbdelHalim HA; Abdellatif M; Bg H; Elnagdy B; Ashraf T; ElNaggar B; S Eldin P; Ta I; Mosaad B; Ismail T; Boules R; Methuselah S; Rafaat P
Open Respir Med J; 2021; 15():46-51. PubMed ID: 35136454
[TBL] [Abstract][Full Text] [Related]
11. Clinical Characteristics and Outcome of Patients With Severe COVID-19 Pneumonia at a Public Sector Hospital in Karachi, Pakistan.
Baqi S; Naz A; Sayeed MA; Khan S; Ismail H; Kumar V; Somjimal H; Aneela J; Imtiaz S; Aftab S
Cureus; 2021 Feb; 13(2):e13107. PubMed ID: 33728127
[TBL] [Abstract][Full Text] [Related]
12. Mortality of Patients With Severe COVID-19 in the Intensive Care Unit: An Observational Study From a Major COVID-19 Receiving Hospital.
Rahim F; Amin S; Noor M; Bahadur S; Gul H; Mahmood A; Usman M; Khan MA; Ullah R; Shahab K
Cureus; 2020 Oct; 12(10):e10906. PubMed ID: 33194473
[TBL] [Abstract][Full Text] [Related]
13. Incidence, Risk Factors and Outcome of COVID-19 Associated AKI- A Study from South India.
Sampathkumar ; Hanumaiah H; Rajiv A; Kumar S; Sampathkumar D; Kumar S; Kumar H; Karthikeyan
J Assoc Physicians India; 2021 Jun; 69(6):11-12. PubMed ID: 34472780
[TBL] [Abstract][Full Text] [Related]
14. Overview of COVID-19 mortality in Zoram Medical College, Mizoram: A hospital-based study.
Laltlanzovi C; Vankhuma C; Vanlalduhsaki ; Chhakchhuak DL; Zothanzauva JC
J Family Med Prim Care; 2023 Feb; 12(2):253-258. PubMed ID: 37091016
[TBL] [Abstract][Full Text] [Related]
15. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
16. Clinical and Epidemiological Features of SARS-CoV-2 Patients in SARI Ward of a Tertiary Care Centre in New Delhi.
Aggarwal A; Shrivastava A; Kumar A; Ali A
J Assoc Physicians India; 2020 Jul; 68(7):19-26. PubMed ID: 32602676
[TBL] [Abstract][Full Text] [Related]
17. High-dose vitamin D versus placebo to prevent complications in COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial (CARED-TRIAL).
Mariani J; Tajer C; Antonietti L; Inserra F; Ferder L; Manucha W
Trials; 2021 Feb; 22(1):111. PubMed ID: 33522946
[TBL] [Abstract][Full Text] [Related]
18. Outcome of early use of non-invasive positive pressure ventilation in patients with acute exacerbation of chronic obstructive pulmonary disease.
Ishfaq N; Gul N; Zaka N
Pak J Med Sci; 2019; 35(6):1488-1492. PubMed ID: 31777480
[TBL] [Abstract][Full Text] [Related]
19. Clinical Profile and Outcome of Haemodialysis in Patients With COVID-19 - A Single Centre Experience.
Vardhan H; Kumar A; Shyama S; Chaudhary N; Pandey S; Rai DK; Kumar D; Kumar S
Cureus; 2021 Aug; 13(8):e17170. PubMed ID: 34548976
[TBL] [Abstract][Full Text] [Related]
20. Clinical Radiological and Biochemical Profile of Moderate to Severe Covid-19 Pregnant Females and its Correlation with Clinical Outcome.
N V; St K; R M; Shenoy V; Patil N
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
